CJC-1295 + Ipamorelin (No DAC)
5 mg CJC-1295 (No DAC) and 5 mg Ipamorelin, co-packed in a single vial.
1 × $40 = $40. Applied in your cart.
- Every batch tested by an independent laboratory — identity by HPLC and mass spec.
- Dispatched on business days once payment has cleared. Free shipping over $100 — flat $10 otherwise.
- Discreet packaging, tracked and insured on every shipment.
For laboratory and research use only · Not for human consumption
- Certificate
- 99.01% purity
- Size
- 10mg
- Form
- Lyophilised powder, single sealed vial
- Storage
- Room temperature, away from light
Measured, not claimed.
Purity by HPLC
From this lot's own certificate, published exactly as the laboratory issued it.
- Lot
- CJCIPA-501
- Tested
- Jul 30, 2026
- Laboratory
- AMINO METRICS
Measured on this lot
- CJC-1295 (No DAC)
- 113.40% of label claim
- IPA (Ipamorelin)
- 111.20% of label claim
Analysed against
- Identity
- HPLC + mass spec
- Purity
- HPLC · figure on the batch COA
- Net peptide content
- HPLC
- Heavy metals
- ICP-MS
- Sterility
- PCR
- Endotoxin
- USP <85>
What it is
This listing supplies two separate research peptides co-packed in a single lyophilised vial: 5 mg of CJC-1295 in its No DAC form and 5 mg of Ipamorelin, 10 mg of peptide in total. They are supplied as a set in one container for convenience of handling. This is not a formulated product, and no combined effect is claimed or implied.
No DAC marks the version supplied without the Drug Affinity Complex — the albumin-binding modification that, in published animal pharmacokinetics, extends how long the peptide persists in circulation. This is the unmodified sequence. The vial arrives as dry powder under seal and must be reconstituted with a sterile solvent before the contents can be worked with; solvent is sold separately. Store the sealed vial at room temperature, out of direct light.
What the research explores
CJC-1295 (No DAC) is a synthetic analogue of growth-hormone-releasing hormone, based on a modified GHRH(1-29) fragment. Preclinical work has characterised its binding at the GHRH receptor on pituitary cells.
Ipamorelin is a pentapeptide described in the pharmacology literature as a selective agonist at the growth hormone secretagogue receptor (GHS-R1a) — a different receptor from the one CJC-1295 acts on.
The two are supplied together because they are commonly sourced together, not because any combined outcome is asserted. Both are research chemicals, and the literature summarised above belongs to each compound separately. Identity and HPLC purity are determined per production lot and reported on the Certificate of Analysis for that lot.
Questions
Are the two peptides in the same vial or separate vials?
Both are in the same sealed vial — 5 mg of each, 10 mg total. They are co-packed as a set, not blended into a formulation.
What does No DAC mean?
It identifies the version of CJC-1295 supplied without the Drug Affinity Complex, the albumin-binding modification. This listing is the unmodified sequence.
How should it be stored?
Keep the sealed vial at room temperature and out of direct light. After reconstitution, refrigerate and treat the contents as a working solution.
What does the Certificate of Analysis cover?
Identity and HPLC purity, issued against the production lot printed on the vial. Two compounds share this vial, so confirm the documentation covers both.
Which lot is CJC-1295 + Ipamorelin (No DAC)'s published certificate for?
Lot CJCIPA-501, measured 99.01% by HPLC, tested Jul 30, 2026, by AMINO METRICS. The full certificate, including the laboratory's own assay rows, is published at /coa/F413-D77C-FDAD-FD48-1A70-72B4-E65C-E638-784B-3AED-4D48-E9E2.
Products are supplied strictly for laboratory and research use. They are not for human or veterinary consumption, and have not been evaluated by the U.S. Food and Drug Administration for the diagnosis, treatment, cure, or prevention of any condition.